Chordia Therapeutics (TSE:190A) OCF Margin %: 0.00% (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:190A Chordia Therapeutics Inc TSE:190A
11 GF Score
Price 円77.00
! 1 Warning Sign
View Full Analysis

What is Chordia Therapeutics OCF Margin %?

Chordia Therapeutics TSE:190A -2.53% 11 OCF Margin % is 0.00% as of Feb. 2026. GuruFocus rates TSE:190A with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 950 Biotechnology companies, Chordia Therapeutics ranks worse than 105263.05% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Chordia Therapeutics's Cash Flow from Operations for the six months ended in Feb. 2026 was 円-611.14 Mil. Chordia Therapeutics's Revenue for the six months ended in Feb. 2026 was 円0.00 Mil. Therefore, Chordia Therapeutics's OCF Margin % for the quarter that ended in Feb. 2026 was 0.00%.

As of today, Chordia Therapeutics's current OCF Yield % is -23.03%.

The historical rank and industry rank for Chordia Therapeutics's OCF Margin % or its related term are showing as below:


During the past 5 years, the highest OCF Margin % of Chordia Therapeutics was 21.75%. The lowest was -68.07%. And the median was -23.16%.

TSE:190A's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -64.565
* Ranked among companies with meaningful OCF Margin % only.

Chordia Therapeutics OCF Margin % Related Terms

Chordia Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Chordia Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordia Therapeutics OCF Margin % Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24 Aug25
OCF Margin %
-68.07 0.00 21.75 0.00 0.00

Chordia Therapeutics Semi-Annual Data
Aug21 Aug22 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
TSE:190A
11GF Score
Chordia Therapeutics Inc TSE:190A
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chordia Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Chordia Therapeutics's OCF Margin for the fiscal year that ended in Aug. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Aug. 2025 )/Revenue (A: Aug. 2025 )
=-1836.921/0
= %

Chordia Therapeutics's OCF Margin for the quarter that ended in Feb. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-611.138/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Chordia Therapeutics (TSE:190A) has a OCF Margin % of 0.00% as of Feb. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Chordia Therapeutics and its competitors. According to the industry distribution chart, Chordia Therapeutics ranks #999999 out of 950 companies in the Biotechnology industry.
Is Chordia Therapeutics' OCF Margin % too high?
Chordia Therapeutics' current OCF Margin % is 0.00%. Based on the distribution chart, Chordia Therapeutics ranks #999999 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Chordia Therapeutics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Chordia Therapeutics' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chordia Therapeutics ranks #999999 out of 950 companies for OCF Margin %. This places Chordia Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Chordia Therapeutics and its competitors. Chordia Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chordia Therapeutics stock overvalued right now?
Chordia Therapeutics (TSE:190A) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Chordia Therapeutics' overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Chordia Therapeutics (TSE:190A), the current OCF Margin % is 0.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chordia Therapeutics Business Description

Address 2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
11GF Score

Get the complete analysis for TSE:190A

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円77.00
Price